Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.46 USD | -1.61% | +3.64% | -19.78% |
09/05 | Intellia Therapeutics' Q1 Net Loss Narrows, Collaboration Revenue Rises | MT |
09/05 | Transcript : Intellia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.78% | 2.36B | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.
- Insider Sell: Intellia Therapeutics